Physician profile
Howard M Ross
NPI 1982634978
$5,570.81
in general payments reported to CMS, 2019-2025
14 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $219 · 2022: $4,208 · 2023: $258 · 2024: $19.52 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.37 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $3,961.47 | 2022-2023 | |
| Medtronic, INC. | $406.95 | 2021-2025 | Signia, Eea |
| Ethicon US, LLC | $310.47 | 2021-2022 | |
| Intuitive Surgical, INC. | $304.03 | 2021-2025 | |
| Biom'Up Sa | $196.12 | 2019 | |
| Stryker Corporation | $135.35 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.68 | 2024-2025 | Entyvio |
| Thd America, INC. | $60.00 | 2025 | |
| Acera Surgical, INC. | $43.32 | 2025 | Restrata Wound Matrix |
| Davol INC. | $25.36 | 2023 | Phasix Mesh |
| Braintree Laboratories, INC. | $19.43 | 2025 | Sutab, Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.68 | 2025 | Xifaxan |
| Lilly USA, LLC | $16.56 | 2025 | Omvoh |
| Mesh Suture INC | $14.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.